https://www.selleckchem.com/pr....oducts/verubecestat.
There were greater improvements in the PM group (n=16) vs. NPM group (n=1 for FEV1 (27.2 ± 6.0% vs. 3.9 ± 6.2%, p=0.017) and FVC (28.1 ± 5.3% vs. -0.5 ± 3.3%, p=0.001). There was no difference in ΔDLCO between groups. There were no differences between patients with PM and NPM in postoperative course/complications. No value for DHI predicted improvement in PFTs following DP. Patients with PM on sniff test have dramatically greater objective improvements in pulmonary function following plication than those without PM. Most patients
Like
Comment
Share
